Improvement in left ventricular mechanics following medical treatment of constrictive pericarditis.


Journal

Heart (British Cardiac Society)
ISSN: 1468-201X
Titre abrégé: Heart
Pays: England
ID NLM: 9602087

Informations de publication

Date de publication:
05 2021
Historique:
received: 10 05 2020
revised: 20 11 2020
accepted: 24 11 2020
pubmed: 8 1 2021
medline: 15 12 2021
entrez: 7 1 2021
Statut: ppublish

Résumé

Patients with constrictive pericarditis (CP) with active inflammation may show resolution with anti-inflammatory therapy. We aimed to investigate the impact of anti-inflammatory medications on constrictive pathophysiology using echocardiography in patients with CP. We identified 35 patients with CP who were treated with anti-inflammatory medications (colchicine, prednisone, non-steroidal anti-inflammatory drugs) after diagnosis of CP (mean age 58±13; 80% male). Clinical resolution of CP (transient CP) was defined as improvement in New York Heart Association class during follow-up. We assessed constrictive pathophysiology using regional myocardial mechanics by the ratio of peak early diastolic tissue velocity (e') at the lateral and septal mitral annulus by tissue Doppler imaging (lateral/septal e') or the ratio of the left ventricular lateral and septal wall longitudinal strain (LS During a median follow-up of 323 days, 20 patients had transient CP, whereas 15 patients had persistent CP. Transient CP had higher baseline erythrocyte sedimentation rates (ESR) (p=0.003) compared with persistent CP. There were no significant differences in LS Improvement of constrictive physiology detected by lateral/septal e' and LS

Identifiants

pubmed: 33408090
pii: heartjnl-2020-317304
doi: 10.1136/heartjnl-2020-317304
doi:

Substances chimiques

Anti-Inflammatory Agents 0
C-Reactive Protein 9007-41-4
Colchicine SML2Y3J35T
Prednisone VB0R961HZT

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

828-835

Informations de copyright

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: ALK: research grant and scientific advisory board for Kiniksa; scientific advisory board for Sobi and Pfizer. PCC: scientific advisory board for Kiniksa.

Auteurs

Kimi Sato (K)

Department of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.

Ayman Ayache (A)

Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Arnav Kumar (A)

Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Paul C Cremer (PC)

Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Brian Griffin (B)

Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Zoran B Popovic (ZB)

Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Christine Jellis (C)

Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Deborah H Kwon (DH)

Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Michael Bolen (M)

Imaging Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Jay Ramchand (J)

Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Michael Chetrit (M)

Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Muhammad M Furqan (MM)

Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Douglas Johnston (D)

Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Allan L Klein (AL)

Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA kleina@ccf.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH